HCM Secondary Listing: Not a Good Performer
After its failed listing attempt 2019, today HCM launched its book building to raise USD 590m in its secondary listing in Hong Kong.Ā We look at...
523 Views
China ADRs - A New Act Aims to Put an End to China ADR IPOs
On 27th May 2021, U.S. Senators Marco Rubio and Bob Casey introduced the No IPOs for Unaccountable Actors Act, which aims to prohibit IPO on U.S....
501 Views
ECM Weekly (14th March 2021) - Coupang, Baidu, Shanghai Heartcare, Chaoju Eye Care, Linklogis, Tuya
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.
588 Views
InnoCare Pharma Ltd (9969.HK) - What Attracts Both Hillhouse and Vivo Capital?
The article analyzed whatĀ InnoCare attracts both Hillhouse and Vivo Capital in terms of its core product orelabrutinib, other products (ICP-192/ICP...
471 Views
BeiGene: Cancer Treatment in China--The Underestimated Opportunity
We think that cancer is underdiagnosed and undertreated in China. We analyze the data and propose two approaches for investing in this theme.
521 Views